HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Reutens, D. C. Articles by Meyer, E. Search for Related Content PubMed PubMed Citation Articles by Reutens, D. C. Articles by Meyer, E.

Regional Lumped Constant Differences and Asymmetry in Fluorine-18-FDG Uptake in Temporal Lobe Epilepsy

Positron Imaging Laboratories
McConnell Brain Imaging Centre
Montreal Neurological Institute
McGill University, Montreal, Canada

Correspondence: For correspondence or reprints contact: David C. Reutens, MD, Montreal Neurological Institute, 3801 University St., Montreal, Quebec, Canada H3A 2B4.

ABSTRACT

To date, there has been no satisfactory explanation for the observation that interictal uptake of the glucose analog [¹⁸F]fluorodeoxyglucose (FDG) is consistently reduced in the temporal lobe ipsilateral to the seizure focus in patients with temporal lobe epilepsy. We examined the hypothesis that regional differences in tracer uptake in temporal lobe epilepsy reflect regional differences in the lumped constant (). Methods: In 9 control subjects and 10 patients with temporal lobe epilepsy, we obtained regional estimates of by expressing in terms of transfer coefficients for FDG and parameters which are likely to remain constant throughout both the brain and under different functional states. Results: In the patients, was lower in the temporal lobe ipsilateral to the epileptic focus (0.53 ± 0.06; p < 0.005) than in the contralateral temporal lobe (0.56 ± 0.06). Interside differences in were highly correlated with asymmetry in tracer uptake. Furthermore, the use of regional estimates of reduced the asymmetry in estimated rCMR_glc in patients with temporal lobe epilepsy but not in controls. Conclusion: In these patients, a change in tracer uptake may not indicate a change in glucose consumption of corresponding magnitude, raising the possibility that in at least some patients with temporal lobe epilepsy, the term hypometabolism does not accurately describe reductions in tracer uptake.

Key Words: fluorine-18-fluorodeoxyglucose • PET • temporal lobe epilepsy